中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
20期
19-20
,共2页
左氧氟沙星%结核性胸膜炎%疗效
左氧氟沙星%結覈性胸膜炎%療效
좌양불사성%결핵성흉막염%료효
Levofloxacin%Tuberculous pleurisy%Efficacy
目的：观察左氧氟沙星联合抗结核化疗药物治疗结核性胸膜炎的疗效。方法：采用回顾性调查与前瞻性结合的方法，比较左氧氟沙星联合抗结核化疗药和单用抗结核化疗药两组方案在治疗结核性胸膜炎的结核中毒症状体征的改善程度、胸腔积液减少程度等指标。结果：左氧氟沙星联合抗结核化疗药组在症状、体征、检查结果上明显好于单用抗结核化疗药组。结论：左氧氟沙星在治疗结核性胸腔积液中的疗效明显。
目的：觀察左氧氟沙星聯閤抗結覈化療藥物治療結覈性胸膜炎的療效。方法：採用迴顧性調查與前瞻性結閤的方法，比較左氧氟沙星聯閤抗結覈化療藥和單用抗結覈化療藥兩組方案在治療結覈性胸膜炎的結覈中毒癥狀體徵的改善程度、胸腔積液減少程度等指標。結果：左氧氟沙星聯閤抗結覈化療藥組在癥狀、體徵、檢查結果上明顯好于單用抗結覈化療藥組。結論：左氧氟沙星在治療結覈性胸腔積液中的療效明顯。
목적：관찰좌양불사성연합항결핵화료약물치료결핵성흉막염적료효。방법：채용회고성조사여전첨성결합적방법，비교좌양불사성연합항결핵화료약화단용항결핵화료약량조방안재치료결핵성흉막염적결핵중독증상체정적개선정도、흉강적액감소정도등지표。결과：좌양불사성연합항결핵화료약조재증상、체정、검사결과상명현호우단용항결핵화료약조。결론：좌양불사성재치료결핵성흉강적액중적료효명현。
Objective:To research the efficacy of levofloxacin joint anti-TB chemotherapy for tuberculous pleurisy.Method:A retrospective survey forward-looking approach compare levofloxacin joint anti-TB chemotherapy drugs and with anti-TB chemotherapy drugs two sets of program signs of improvement in the treatment of tuberculous pleurisy symptoms of Tuberculosis,pleural effusion,the degree of reduction and other indicators. Result:The levofloxacin Joint anti-TB chemotherapy drug group in symptoms,signs,test results was significantly better than a single anti-TB chemotherapy drug group. Conclusion:Levofloxacin is effective in the treatment of tuberculous pleural effusion.
